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Ryan J. Martinez and Brian D. Evavold *
Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA
Kinetic and biophysical parameters of T cell receptor (TCR) and peptide:MHC (pMHC) 
interaction define intrinsic factors required for T cell activation and differentiation. 
Although receptor ligand kinetics are somewhat cumbersome to assess experimentally, 
TCR:pMHC affinity has been shown to predict peripheral T cell functionality and potential 
for forming memory. Multimeric forms of pMHC monomers have often been used to 
provide an indirect readout of higher affinity T cells due to their availability and ease of use 
while allowing simultaneous definition of other functional and phenotypic characteristics. 
However, multimeric pMHC reagents have introduced a bias that underestimates the 
lower affinity components contained in the highly diverse TCR repertoires of all polyclonal 
T cell responses. Advances in the identification of lower affinity cells have led to the 
examination of these cells and their contribution to the immune response. In this review, 
we discuss the identification of high- vs. low-affinity T cells as well as their attributed 
signaling and functional differences. Lastly, mechanisms are discussed that maintain a 
diverse range of low- and high-affinity T cells.
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introduction
The T cell immune response is composed of diverse sets of T cell receptors with a normally distributed 
range of affinities for pMHC (1, 2). Upon antigen recognition, the biophysical characteristics of the 
TCR:pMHC interaction will drive signaling, division, and differentiation (3, 4). Current hypotheses 
suggest the highest affinity T cells have a competitive advantage during the immune response, based 
on the assumption that they would receive stronger and more prolonged activation signals than T 
cells with lower affinity interactions (5–7). However, evidence is emerging to suggest the lack of 
skewing toward the highest affinity T cell repertoire, instead of proposing a distribution of affinities 
and maintenance of diversity throughout the immune response (8, 9). This T cell diversity has been 
shown to be important for homeostasis of the immune system, but the process of maintaining affinity 
diversity is unclear. We further discuss factors that support and favor the survival of lower affinity T 
cells and, therefore, highlight the important contribution of low-affinity T cells and a broad affinity 
distribution in the immune response.
Measurement of TCR:pMHC Affinity
Affinity is defined as the probability of a receptor (TCR)–ligand (pMHC) interaction and is one 
of the most commonly used measurements to predict the T cell response to antigen. As with all 
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receptor–ligand interactions, affinity, or the association con-
stant (Ka) is derived from the on-rate (kon) and off-rate (koff) of 
receptor–ligand equilibrium and is calculated independently of 
concentrations of ligand and receptor (affinity =  Ka =  kon/koff) 
(Table  1) (3, 10). The affinity of an interaction is not its bond 
strength, or the force needed to break the bond, though these 
terms are often incorrectly used interchangeably. An example of 
this distinction can be seen in the avidin/biotin system as this 
receptor–ligand pair has one of the highest affinity interactions 
measured, but the non-covalent interactions can be easily broken, 
signifying lower bond strength (11). Along with TCR:pMHC 
affinity, the dissociation constant (Kd, inverse of Ka) and half-life 
[τ1/2 =  ln(2)/koff] can also be derived. The combination of these 
measurements have been used to describe T cell activation and 
differentiation models (kinetic proofreading, optimal dwell time, 
etc.), but not all methods of biophysical measurements generate 
similar results (3, 12, 13). Therefore, further understanding of 
measurement systems is necessary.
Affinity is commonly measured using purified reactants in 
solution by surface plasmon resonance (SPR), where free ligand 
is flowed over receptors fixed to a surface. This absolute affinity 
measurement occurs in three dimensions (3D) and allows for the 
definition of protein interactions in their simplest, purified form 
with no influence from outside forces. However, the increased 
degrees of freedom that occur in solution may not be the opti-
mal method to accurately assess interactions between receptor 
and ligands that occur in two opposing plasma membranes. A 
better replicate of in  vivo interactions between proteins at the 
membrane surface can be accomplished using two-dimensional 
(2D) receptor–ligand binding techniques, such as flow chamber 
assays, thermal fluctuation assays, single molecule FRET, Zhu–
Golan plots, contact area FRAP, and the adhesion frequency assay 
TABLe 1 | Definitions of biophysical parameters of TCR:pMHC 
interaction.
Keyword Definition
Affinity Tendency of association between a monovalent  
receptor–ligand pair at equilibrium. Two types of affinity 
measurements can be appreciated
Absolute affinity: affinity measurement using purified receptor 
and ligand without cellular context
Relative affinity: affinity measurement of receptor–ligand 
interactions in cellular membranes to recapitulate native 
interactions
Avidity Tendency of association between multivalent entities at 
equilibrium. This is not the sum of affinities as the binding of 
one receptor–ligand pair increases the likelihood of another 
receptor–ligand pair interaction due to reduced proximity and 
degrees of freedom
Association 
constant (Ka)
The equilibrium constant of the association of a receptor and 
ligand
Dissociation 
constant (Kd)
The equilibrium constant of the dissociation of a  
receptor–ligand interaction
On-rate (kon) The rate at which a receptor and ligand bind to form a complex
Off-rate (koff) The rate at which a receptor–ligand complex reverses binding
Half-life (τ1/2) The amount of time needed for half of the receptor–ligand 
complexes to reverse binding
(3). Currently, the focus of our lab has been the use of the two-
dimensional micropipette adhesion frequency assay (2D-MP), a 
measurement of the relative 2D affinity of the receptor–ligand 
interaction on opposing membranes (14). This 2D affinity is 
termed a relative affinity because it is dependent on the context 
in which it was measured, whereas 3D methods generate an 
absolute affinity measurement while ignoring all other cellular 
participants. This distinction of relative and absolute affinity will 
be discussed in a later section. When 2D and 3D affinity TCR 
measurements are compared, an increased affinity with an associ-
ated decreased koff can be appreciated (12, 13, 15, 16). Attempts 
to correlate affinity values generated by 2D and 3D methods have 
been achieved with little success as the parameters controlling 
relative 2D affinity are still unknown (12). Importantly, the rela-
tive affinity measured by 2D-MP better correlates with functional 
responses than 3D methods and refers to the affinity in the proper 
cellular context (12, 15).
The advent of recombinant pMHC tetramer reagents has 
allowed for the identification of antigen-specific T cells and 
the subsequent use of these reagents for indirect assessment 
of biophysical interactions of TCR:pMHC. The binding of the 
tetramer reagent is dependent on valency to increase its avidity 
as monomeric pMHC complexes do not attach well to TCR (17, 
18). This lack of monomer interaction with TCR is most likely 
due to the reliance of pMHC tetramer staining on higher affinity 
interactions (8, 9). The koff and kon for each arm of the pMHC 
tetramer binding to TCRs are known to reflect avidity interac-
tions, with the binding of one pMHC monomer arm enhancing 
the kon of the subsequent monomer arm and reducing the koff of 
the entire reagent (19). The use of pMHC tetramer to measure koff, 
kon, and τ1/2 assumes that the amount of pMHC tetramer bound to 
a cell is directly proportional to the affinity of that cell, with more 
tetramer bound to higher affinity cells than to lower affinity T 
cells (6, 9, 19, 20). However, this assumption may not always yield 
a direct correlation, with many groups demonstrating tetramer 
binding intensity does not equate to functional responses or SPR 
measurements (21–24). One possible explanation for discrepan-
cies with SPR is that the cellular membrane can affect tetramer 
binding. Another possibility for these discrepancies is that 
TCR density affects binding because tetramer relies on avidity 
interactions. While many have normalized the TCR to pMHC 
concentrations on each cell (18, 25, 26), others do not account 
for the number of TCRs expressed at the cell surface (21, 27, 28). 
The effect of TCR density can be appreciated as the analysis of 
the tetramer+ populations reveals lower TCR expression as they 
exhibit only 20–40% of the TCR density compared to the bulk 
T cell population (unpublished data). This indicates tetramer+ 
T cells may have different TCR levels than the remaining T cell 
population but it is unknown if this is a cause or an effect of being 
a tetramer binder.
The measurement of TCR:pMHC affinity by 2D-MP is an 
extremely sensitive method that follows first-order kinetics 
and is dependent upon T cell intrinsic factors (3). Measured 
TCR affinities can be altered when reagents are used to change 
lipid composition and actin cytoskeleton (12). Adjustments 
of the membrane and supporting scaffolding should change 
2D affinity as the characteristics of the opposing membranes 
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during receptor–ligand interactions are fundamental for the 
measurement of relative 2D affinities. Much of the sensitivity 
of the 2D-MP assay comes from the flexibility of the red blood 
cell (RBC) membrane, which can be distended by the formation 
of a single TCR:pMHC bond (3, 29). As biotinylated pMHC is 
bound to the RBC through streptavidin interactions, clustering 
and valency of ligand could play a role in binding. Varying the 
concentration of pMHC on the RBC surface does not change the 
calculated affinity of activated T cells, signifying concentration 
does not affect the 2D measurements (12, 14). In experiments 
altering the valency of pMHC on the RBC through use of mutant 
streptavidin, no changes in 2D affinity were noted (12). This is in 
contrast to pMHC tetramers, which rely on both concentration 
and valency of the reagent to measure antigen specificity (30). 
Together, this suggests concentration and valency do not play 
a role in the measurement of affinity by 2D-MP. In addition, it 
demonstrates the micropipette values are a measure of affinity 
and not avidity.
An important distinction between CD4 and CD8 T cells is 
the contribution of coreceptor to the overall strength of binding 
between pMHC and TCR (18, 31). CD4 and CD8 coreceptors are 
thought to stabilize TCR:pMHC bonds while also recruiting Lck 
to the TCR complex for the initiation of the downstream signal-
ing cascade (32, 33). Intriguingly, CD8 has a higher affinity for 
its coreceptor than CD4, though both interactions are of weaker 
affinity (13, 32). For CD8 T cells, coreceptor contributes to the 
binding of TCR to pMHC when assessed by pMHC tetramer, 
2D-MP, and SPR (31, 34–36). The removal of CD8 contribution 
leads to decreased avidity and functional responses (37–39). In 
addition, the binding of the lowest affinity T cells are the most 
affected by the loss of CD8, signifying CD8 helps to increase the 
likelihood of low-affinity TCR:pMHC interaction and signaling 
(15, 37). In contrast, the role of CD4 is very different as there is lit-
tle to no contribution to the TCR:pMHC interaction as measured 
by 2D-MP, pMHC tetramer, and SPR (13, 32). This is not to say 
CD4 is not important in functional responses as CD4 is required 
to recruit Lck for optimal initiation of T cell signaling (17, 40, 
41), but at least under the conditions used in tetramer and 2D 
assays, there is little contribution to biophysical parameters (13). 
Importantly, detection of CD4 T cells by pMHCII tetramer would 
be expected to miss more of the lower affinity TCRs due to the 
lack of coreceptor contribution as compared to pMHCI tetramer 
and CD8 T cells. These differences in CD4 and CD8 coreceptor 
binding impact the use of tetramers to count antigen-specific T 
cells as well as measuring the kinetic rates of the TCR:pMHC 
interaction.
Detection of Antigen-Specific T Cells
The identification of T cells is important as the biophysical 
TCR:pMHC interactions discussed are correlated with functional 
responses. The current gold standard for identifying antigen-
specific T cells are using either pMHC tetramer reagents or 
readouts of functional responses, but both are sub-optimal in 
identifying the true number of antigen-specific T cells (42–45). 
For example, not all T cells of the same specificity make cytokine 
upon stimulation as demonstrated by the use of TCR-Tg T cells 
(46, 47). Further, a CD4 T population has a number of distinct 
fates with associated effector functions, such that any one cytokine 
will underestimate the total number of antigen-specific cells. 
Interestingly, the number of pMHC tetramer+ T cells sometimes 
equates to the number of cytokine-producing cells, even though 
not all T cells will produce the target cytokine (27, 43, 45). For 
the most part, intracellular staining for cytokines is incompatible 
with tetramer staining making it unclear if cytokine-producing 
cells overlap with tetramer binders, or if they are distinct popula-
tions. To more accurately identify the number of antigen-specific 
T cells, groups have used activation markers, such as CD11a, 
LFA-1, or CD49d, that are upregulated on antigen-specific T cells 
after infection (43, 48). When these cells are quantitated using 
these functional cell-surface markers, they far outnumber the 
number of tetramer or cytokine-producing cells (43, 48). The 
2D-MP further corroborates the underestimation of antigen-
specific T cells by pMHC tetramers (8, 9). When compared to 
the total population of antigen-specific T cells, pMHC tetramer+ 
T cells make up only the highest affinity population (9). Most T 
cell repertoires have a normally distributed TCR:pMHC affinity 
range, with the rarest cells being the highest and lowest affinity. 
Based on this data, tetramer+ cells are above average in affinity 
and would, therefore, only make up a fraction of the total T cells 
in an immune response (4). This would be especially apparent for 
CD4 T cells since the coreceptor does not aid in tetramer avidity.
The 2D-MP assay is currently the most sensitive available to 
capture the entire affinity range of a T cell repertoire and not just 
the highest affinity T cells. To perform the 2D-MP assay, single 
T cells are randomly chosen for affinity measurements from a 
purified population of cells. As this is a sampling process that 
is time intensive, it is important to understand the numbers of 
cells needed for analysis to reflect representative data of the entire 
population. To address how many cells need to be measured to 
find the average affinity of an antigen-specific polyclonal popula-
tion, we have combined previously published measurements of a 
polyclonal T cell population for a single antigen (MOG38–49:I-Ab) 
and performed random sampling experiments (Figure 1). When 
noting the moving average from 10 repetitions of the randomly 
sampled MOG-specific T cell affinities, it is apparent that the 
sampling affinity often reaches the average affinity rapidly, i.e., 
within 10 binding pairs. By the time, 16 binding T cells have been 
analyzed, the average affinity measured is ±5% of the affinity of 
the entire pooled population. This measurement is for a poly-
clonal population with a 2,000-fold range in affinity, meaning a 
repertoire with considerably less diversity (TCR-Tg or tetramer+ 
T cells) needs even fewer points measured to identify the average 
affinity. Therefore, to measure the average affinity of a normally 
distributed polyclonal repertoire only 10–16 T cell affinities need 
to be measured to be within 5% of the average affinity of the 
repertoire.
Signaling in Low-Affinity T Cells
In both kinetic-segregation and proofreading models, the bind-
ing of TCR:pMHC is key to activation, with the koff and kon and 
τ1/2 controlling the strength of signal the T cell receives (49–53). 
Higher affinity interactions with prolonged τ1/2 have an increased 
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likelihood of forming a stable conjugate and triggering the T 
cell signaling cascade, though an optimal τ1/2 most likely exists 
due to the hypothesized need for serial engagement (10, 50, 53). 
Using this logic, the lowest affinity T cells should have a reduced 
probability of initiating T cell signaling, but these cells do effi-
ciently propagate the signaling cascade as low-affinity T cells do 
expand, and differentiate during the immune response (8, 9, 48). 
Thus, mechanisms must exist that allow for low-affinity T cells, 
with the reduced probability of initial TCR:pMHC bond forma-
tion, to receive sufficient signals to compete with high-affinity 
counterparts.
Developing thymocytes discriminate positive- and negative-
selecting signals through both qualitative and quantitative 
signaling pathways. Qualitatively, studies have suggested that 
reduced but sustained Erk signaling is necessary for positive 
selection, while strong Erk, p38, and Jnk activation are necessary 
for negative selection (54–57). In positive selection, the protein 
Themis reduces TCR signaling by recruiting the phosphatase 
SHP-1 to inhibit Lck activation and reduces strong, transient, Erk 
activation, a property associated with negative selection (57, 58). 
Without Themis, low-affinity pMHC can produce strong agonist 
signals resulting in increased negative selection (58). This is of 
interest as negative regulatory mechanisms must be preventing 
low-affinity ligands from being selected like high-affinity ligands. 
Currently, it is unknown what controls the function of Themis or 
how it discriminates between high- and low-affinity pMHC to 
ultimately regulate downstream signals. One potential quantita-
tive mechanism for discriminating high- and low-affinity pMHC 
was found in thymocyte negative selection. During negative 
FiGURe 1 | Random sampling of measured TCR:pMHC reveals rapid 
approach to average affinity for an entire population. Previous 2D 
affinity measurements of MOG-specific CD4 T cells were combined and 
randomly arranged. A moving average was calculated and graphed as a 
function of the number of cells sampled. Cells were then randomly 
rearranged and moving average calculations were performed nine more times 
to generate the curves illustrated.
selection, thymocytes bind to pMHC and scan coreceptors (CD4 
and CD8) to find one coupled to Lck (59). CD8 coreceptors 
on thymocytes have a lower amount of coupled Lck than CD4 
coreceptor, so a longer TCR:pMHC τ1/2 is necessary for CD8 T 
cell negative selection (59). If a TCR:pMHC bond is maintained 
during the duration for a coreceptor-Lck conjugate to be found, 
the T cell is determined to be high affinity and will undergo Bim-
dependent apoptosis (60). These differences in signaling between 
positive and negative selection demonstrate how similar stimuli 
(pMHC) can generate distinct results depending on the TCR 
interaction parameters.
Naive CD4 and CD8 T cells demonstrate a distribution of 
reactivity to multiple foreign antigens that is established during 
thymic selection on self-antigens. In both naïve CD4 and CD8 T 
cells, multiple studies have been able to identify heterogeneity in 
reactivity of T cells for self- and foreign-pMHC (26, 61–64). These 
ranges of reactivity relate to markers of self-pMHC stimulation 
(CD5, Nur77, basal TCRζ phosphorylation) (26, 61, 64, 65) as well 
as indicators of activation in response to foreign-pMHC (ERK 
phosphorylation, IL-2 production) (64). Conflicting experimen-
tal evidence exists when attempting to correlate self-reactivity 
with foreign-reactivity (26, 61, 64). Some have demonstrated that 
CD5 positively correlates with foreign TCR reactivity (measured 
by pMHC tetramer and function) (26, 61), while others have 
demonstrated CD5 expression can be altered without changes 
to TCR affinity as measured by SPR (64). Nonetheless, based on 
the TCR affinity for self-pMHC, the immune system is able to 
diversify the reactivity of signaling machinery by controlling the 
basal phosphatase and kinase activity.
The first step of signaling after TCR triggering is phospho-
rylation of CD3 and TCRζ intracellular chains by Lck and the 
recruitment of the kinase Zap70. Phosphorylation of Zap70 by 
Lck propagates the initial signals and causes downstream activa-
tion of the MAP kinase (Erk), NF-κB, and calcineurin pathways 
(66). To inhibit signaling cascades, phosphatases, such as SHP-1/2 
and CD45, prevent the sustained activation of kinases (66). For 
low-affinity TCR:pMHC interactions, the peak of T cell signaling 
molecules (Erk, Jun, and Ras) are delayed or absent and TCR sign-
aling is decreased (58, 62, 67). This late and reduced activation of 
Erk in low-affinity T cells allows for the sustained recruitment and 
activity of SHP-1, decreasing the activation of Lck and reducing 
the T cell signaling response (58, 67, 68). Another phosphatase, 
PTPN22, has also been shown to inhibit Erk phosphorylation in 
T cells stimulated with low-affinity pMHC (69). It is surprising 
that even with these negative signaling events, low-affinity TCRs 
are able to signal and even upregulate activation genes CD69 and 
CD25 to similar levels as higher affinity T cells (7, 67). Similar to 
thymocyte selection, this demonstrates peripheral T cells have 
mechanisms to detect biophysical TCR interactions that can then 
be translated to signaling cascades as well as possess compensatory 
mechanisms to enhance low-affinity TCR interactions or even 
decrease higher affinity T cell interactions (70). Potentially, force 
generation by TCRs could be a mechanism by which low-affinity 
T cells are able to increase bond τ1/2 and receive similar signals as 
high-affinity counterparts (71–73). Conversely, it may be that dif-
ferent pathways are induced by low-affinity TCR:pMHC binding 
that are currently not understood. Overall, low- and high-affinity 
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T cells use similar mechanisms and machinery to signal, but the 
outcomes seem to vary in their response.
Functionality of Low-Affinity T Cells
The development and function of T cells has been highly associ-
ated with TCR:pMHC affinity, with high- and low-affinity T cell 
interactions often performing different roles. Thymocyte selec-
tion is dependent upon TCR:pMHC affinity interactions, with 
positive selection requiring low-affinity interactions and negative 
selection deleting thymocytes greater than a threshold affinity (1, 
74). The number of antigen-specific T cells for a single epitope 
is tightly controlled by central tolerance and, therefore, by TCRs 
affinity for self-pMHC presented in the thymus (75–79). The 
initial numbers of DP thymocytes for a single epitope are defined 
by the size of their positively selecting niche of self-peptides 
and further culled by their reactivity to self-antigen via nega-
tive selection (27, 63, 79–81). Work suggests positive selection 
is important in the generation of a functional T cell repertoire 
as alterations in the size of the selecting niche can cause T cell 
dysfunction or increased reactivity to antigen (63, 82). Analysis 
of the autoimmune prone NOD mouse has suggested its positive 
selecting niche is reduced, causing competition for positive selec-
tion survival signals and enriching for T cells that have a higher 
affinity TCR:self-pMHC interaction (81). This reduced positive 
selection niche and concurrent increase in TCR affinity will not 
be fully compensated by negative selection as negative selection 
is not as effective as once believed (63, 81, 83–85). The precursor 
frequency of a given antigen-specific T cell repertoire reproduc-
ibly generated by thymocyte selection is important as antigens 
with higher precursor frequencies can reach peak numbers more 
rapidly and provide better immune protection (27). Antigen-
specific T cell repertoires with lower precursor frequencies 
will have a greater fold expansion, but will still not outnumber 
the higher precursor frequency repertoires (86). Based on this 
functional data, one could assume that the repertoires with larger 
precursor frequency have a higher affinity for pMHC as this 
would mean they have undergone less negative selection. Recent 
work supports this hypothesis as epitopes with lower precursor 
frequency demonstrate more similarity to mouse self-peptides 
as well as reduced pMHCII tetramer binding (27). Therefore, a 
balance exists between positive and negative selection and their 
preference to favor low- and high-affinity interactions between 
pMHC and TCR will ultimately determine the numbers and 
affinity of antigen-specific T cells.
All the advantages of TCRs with high affinity for pMHC would 
suggest they can easily outcompete the lower affinity T cells (5), 
but this does not seem to be occurring when the full affinity rep-
ertoire is analyzed (8, 9, 48). One caveat to many model systems is 
the focus on a single TCR and the use of different APLs to model 
the fate of polyclonal T cells in response to lower affinity antigens 
(7, 59, 87–89). In TCR-Tg mice, each T cell undergoes similar 
thymic selection mechanisms, and therefore possesses similar 
reactivity to antigen. Groups have shown different repertoires 
undergo different TCR selection and peripheral tolerance mecha-
nisms, including negative selection, agonist selection, clonal 
diversion, and inhibitory molecule upregulation (65, 70, 74, 90, 
91). For example, every OT-I TCR-Tg T cell will be positively and 
negatively selected by the same self-antigens, while in a polyclonal 
system, T cells with a range of affinities will recognize the OT-I 
cognate peptide (SIINFEKL) and will be positively and negatively 
selected by numerous different peptides. In the polyclonal setting, 
there will be a range of affinities for SIINFEKL and an accom-
panying range of tolerance mechanisms to control responses to 
this antigen. Therefore, a single TCR binding to different affinity 
pMHC complexes during selection is not the same as a polyclonal 
set of different TCRs binding to a set of pMHC. This distinction 
between effects at a clonal as opposed to a polyclonal level could 
alter functionality and impact interpretation on the role of lower 
affinity ligands during an immune response.
After primary antigen exposure and triggering of signaling 
cascades, division of CD4 and CD8 T cells will cause 100- to 
1,000-fold expansion (61, 86, 92). Interestingly, low-affinity T cells 
are easily detectable throughout the response, signifying they are 
capable of expanding as well as high-affinity T cells (9, 48). Higher 
affinity CD8 TCR interactions cause asymmetric division that is 
associated with increased functionality of the proximal daughter 
cells (89). These CD8 T cells have similar initial rates of division, 
but eventually the highest affinity T cells maintain division while 
the lower affinity T cells begin to contract (7, 89). The contraction 
of lower affinity T cell is not due to increased death or lack of 
memory formation as a similar frequency of low-affinity pMHC 
primed CD8 T cells differentiates into memory T cells (88, 89). 
Along with differences in division rates, the migration kinetics 
of T cells are controlled by affinity, with the lower affinity APL 
stimulated T cells demonstrating increased numbers of TCR-Tg 
T cells in the blood at earlier time points (7). Studies in high- and 
low-affinity CD4 T cells demonstrates the time to the first divi-
sion of high-affinity CD4 T cells is much faster than low-affinity 
cells, though after several divisions, the low-affinity cells reach 
the same absolute number as high-affinity T cells (67). Together, 
these data demonstrate low- and high-affinity T cells behave 
similarly during initial expansion, but most likely have roles in 
the immune response at distinct times and locations.
Evidence demonstrates T cell affinity controls effector and 
memory differentiation of antigen-specific populations. Using 
the OT-I CD8 T cell APL system, groups have demonstrated 
low-affinity priming generates a greater frequency of Eomes+ 
memory T cells (88). It was determined that TGF-βR expression, 
a negative regulator of T cells, is not downregulated in low-affinity 
T cell responses, creating a balance of the generation (IL-12R) 
and ablation (TGF-βR) of memory T cells (88). In CD4 T cells, 
TCR:pMHC affinity has been correlated with memory (6, 93, 94), 
T helper subset (TH1 vs. TH2), and T follicular helper (TFH) dif-
ferentiation (92, 93, 95, 96) as well as prevention of exhaustion by 
chronic antigen exposure (97). Lower affinity TCR interactions 
have been shown to be biased to generate long-lived memory cells 
(6, 93, 94), while for TH1 vs. TH2 differentiation, greater strength 
of TCR stimulation increases the likelihood of TH1 differentiation 
(95, 96). For TFH cells, increased and decreased TCR:pMHC affin-
ity has been correlated with differentiation, thought to be due to 
TCR-dependent IL-2/IL-2R alterations (28, 92, 93). The finding 
that TFH cells can differentiate from TCRs with low and high-
affinity TCR:pMHC interactions is perplexing, but demonstrates 
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that active mechanisms maintain the differentiation diversity of 
the low and high-affinity T cells. Nonetheless, comparing and 
contrasting the findings of CD4 and CD8 T cells demonstrates 
the complexity of each system, but also demonstrates unique roles 
and pathways for high- and low-affinity TCR:pMHC interactions 
to presumably maintain functional diversity.
The activation and regulation of metabolic pathways is essen-
tial for the initiation and maintenance of the immune response 
(98–101). In CD8 T cells, the TCR:pMHC interaction controls 
initial metabolic reprograming by upregulating IRF4 and Myc in 
a TCR:pMHC affinity-dependent manner (101). The transcrip-
tion factors Myc and IRF4 coordinate the switch from fatty acid 
oxidation to aerobic glycolysis, which is essential for maintenance 
of the immune response (99, 101). Low-affinity TCR interactions 
led to less Myc and/or IRF4 expression, reducing the uptake 
of metabolic intermediates and changing the amount of T cell 
death during the response (99, 101). Therefore, TCR:pMHC 
affinity is necessary for instructing metabolic reprograming and 
a generating a greater functional response, but it is still unclear 
what function affinity-based metabolic reprograming plays for 
the differentiation and maintenance of low-affinity T cells.
Maintenance of Affinity Diversity
The maintenance of clonotype diversity in the immune system 
is essential for the health of the organism (102). By maintaining 
clonotype diversity, TCR affinity diversity is also preserved, with 
a single epitope being recognized by multiple T cells to create a 
normally distributed TCR:pMHC affinity population. For each 
epitope, a range of T cell precursors exist, whose frequency is 
controlled by central tolerance mechanisms (27, 103). As the 
preimmune frequency for a single epitope approaches 0, the 
capacity of the repertoire to protect the host from this epitope 
diminishes (90, 104). This theoretical lower limit of T cells that 
can effectively protect the host is defined as a protecton and is 
dependent upon the size of the organism and the migration 
velocity of T cells (105). Larger organisms need a larger protecton 
because their bodies have a greater volume to patrol and protect 
against pathogen dissemination.
Along with the size of the organism, the protecton is depend-
ent upon the amount of cross-reactivity between TCRs. To 
derive the level of cross-reactivity inherent to an individual’s 
TCRs, the entire number of antigen-specific T cells inclusive 
of lower affinity ones needs to be defined. Recent studies have 
identified T cells with cross-reactivity using multiple high-
affinity-dependent methodologies, such as pMHC tetramers, 
but the rules regulating cross-reactivity are still being formu-
lated (27, 104, 106, 107). Previous studies have suggested that the 
highest affinity T cells are the most cross-reactive as these cells 
have been shown to accept the most degeneracy in TCR:pMHC 
interaction and still function (108–110). However, single T cells 
can have both increased and decreased functional responses to 
peptides, meaning that just because a TCR binds to one pMHC 
with lower affinity, it cannot bind to another pMHC with 
higher affinity (106). Theoretically, a single TCR should possess 
a range of affinity for peptides presented by MHC, meaning 
that cross-reactivity is not unique to only high- or low-affinity 
TCRs. Groups have identified low-affinity T cells during the 
immune response, signifying these cells must be represented in 
the naïve mouse, yet these lower affinity T cells are currently 
not being included in the calculations (8, 9, 48). If inclusion of 
lower affinity T cells leads to a greater number of T cells in an 
antigen-specific repertoire, then the amount of cross-reactivity 
would correspondingly change (104). Therefore, protecton size 
and cross-reactivity calculations may be inaccurate due to the 
exclusion of these cells.
Low-affinity T cells are effective immune mediators and can 
have dominant roles in the immune response under specific con-
ditions (62, 88, 111–113). When T cell clones are compared for 
their ability to cause autoimmunity, combat infection, or prevent 
tumors, low-affinity T cells are often comparable in accomplishing 
these tasks (22, 62, 97, 112, 113). For example, when a lower affin-
ity CD8 T cell clone specific for an influenza antigen is transferred 
into a mouse expressing the antigen in a tumor, little immune 
response occurs (113). However, when this mouse is infected with 
influenza and/or given CD4 T cell help, the low-affinity T cells 
can respond with enhanced function (113). Along with influenza, 
groups have demonstrated adjuvants, such as CFA, MPL, and 
Listeria monocytogenes, can generate a larger population of low-
affinity T cells (6, 112, 114, 115). Besides adjuvants, the form of 
antigen can control low-affinity T cell expansion as the use of pro-
tein antigen has been demonstrated to recruit more low-affinity T 
cells into the immune response (94). Why antigen and adjuvant 
influence the affinity diversity of the T cell response is still unclear, 
though these factors point to the type of antigen presenting cells 
(APCs) as a possible manipulator of low- and high-affinity T cell 
skewing. This suggests high- and low-affinity T cells may compete 
for TCR signaling, but mechanism, such as antigen processing and 
presentation, may maintain and influence the affinity diversity.
Alteration of APC by using different adjuvants or forms of anti-
gen is one way to potentially alter T cell diversity, but can diversity 
of affinity be regulated in a T cell intrinsic fashion? As previously 
mentioned, the 2D affinity measurement by 2D-MP is a relative 
affinity, dependent unknown factors as well as the contact area 
restricting the receptor and ligand interactions. Our work reveals 
slightly different affinities (<10-fold) for thymocytes, peripheral 
naïve TCR-Tg T cells, and activated T cells demonstrating that 
the context of the membrane environments plays a role [(13) 
unpublished data]. Thymocytes, naïve, and activated T cells are 
different sizes, which may alter contact area between the T cell 
and RBC during the 2D-MP measurement. At the macroscopic 
level, the contact area difference between thymocytes and naïve 
T cells seems negligible, but in fact could result in differences 
as lymphocytes contain excess membranes, which is stored in 
ruffles and protrusions that could change during development 
and activation state (116). If there are differences in the ruffling 
of the membrane along with size differences, the membrane sur-
face area in contact containing the TCR and pMHC could vary 
between different populations of cells. Of note, within a given 
population of cells, the surface area would be similar allowing 
for accurate affinity measures. These effects on membrane surface 
would also be predicted to influence lymphocyte function in vivo, 
which could be why 2D affinity so accurately predicts the level of 
functional response.
September 2015 | Volume 6 | Article 4687
Martinez and Evavold Low-affinity T cell importance in the immune response
Frontiers in Immunology | www.frontiersin.org
In addition, 2D affinities are dependent on the local membrane 
structure that is maintained by the actin cytoskeleton and con-
trolled by the membrane lipid composition. During TCR activa-
tion, the actin cytoskeleton is remodeled (117). This cytoskeleton 
change could alter the 2D-MP affinity as the integrity of the 
membrane structure and orientation of the surface proteins will 
also fundamentally change. Inhibition of actin polymerization 
has been demonstrated to reduce 2D affinity as well as functional 
responses (12, 13). The actin inhibitors again demonstrate how 
2D-affinity measurements accurately readout the functional-
ity of the TCR interaction with pMHC (12, 15). A T cell could 
manipulate its 2D affinity through changes in the cytoskeletal 
support and protein attachment to actin. Alternative 2D affinity 
could be regulated to a degree by alterations in lipid content as 
CD4 T cell subsets contain differential organization of lipids (118, 
119). Lipid composition has not been studied in relation to 2D 
affinity, but lipid order and organization has been demonstrated 
to be important in T cell functional responses, implicating the 
affinity may be different (118, 119).
Other surface proteins could influence the ability of the TCR 
to interact with pMHC and the 2D affinity. In the kinetic-segre-
gation model of T cell activation, the size of the CD45 molecule 
regulates the interaction of TCR:pMHC, with its exclusion from 
the synapse a necessary step to initiate the T cell signaling cascade 
(51, 52). T cell expression of a smaller isoform of CD45 would 
reduce steric hindrance and could increase the TCR:pMHC 
affinity measured by 2D-MP. Therefore, when the 2D affinity is 
calculated in the context of the cellular membrane, multiple T 
cell intrinsic factors can tune its measured value. In  vivo, this 
fine-tuning of 2D affinity could be envisioned as a mechanism 
allowing for small alterations in the likelihood of TCR engage-
ment (affinity for pMHC) while maintaining the diversity of the 
immune response.
Summary
Evidence demonstrates lower affinity T cells most likely have 
overlapping and distinct roles when compared to T cells with 
higher affinity interactions. Low-affinity T cells use much of the 
same signaling machinery for generating an immune response, 
but also must possess unique pathways or factors to sustain func-
tion and prevent excessive negative regulation during signaling. 
During differentiation, low-affinity T cells can again be found to 
have shared and unique roles when compared to higher affinity 
T cells. Low and high-affinity T cells must function together to 
efficiently generate a complete immune response and maintain 
the diversity of TCR affinity to efficiently protect the host.
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